-
From the CEO
Click to read the full issue
This issue of Forum demonstrates the broad scope and deep impact of Analysis Group’s ongoing work on behalf of our clients. We continue to use leading-edge methodologies and analysis to tackle issues across virtually every sector in the landscape of economic and litigation consulting.
Our teams are exploring new applications for machine learning and big data in different types of litigation support. Exciting developments in other evolving areas include examining the bases of competition for biosimilar products introduced in the pharmaceutical market; clarifying key privacy and data security issues in the online world; analyzing the impact of new regulatory requirements in the area of labor and employment; and providing analytical insights into new frameworks for clean energy. We also strengthened our relationships with groundbreaking thinkers in the field of economics.
Our firm continues to grow – in size, geographic reach, depth of expertise, and scope of our extensive network of affiliates. We also recently modified our firm leadership. While continuing as CEO, I am now also Chairman of Analysis Group’s Board of Directors. Pierre Cremieux is now President, and Bruce Stangle, formerly Chairman and Co-founder, continues as Co-founder.
We remain committed to our distinctive, collaborative culture, which provides the underpinning for the success of our firm and our clients.
— Martha S. Samuelson, CEO and Chairman
-
Using Machine Learning in Litigation
Advances in machine learning can help attorneys and their experts harness the proliferation of data that is requiring analyses beyond the limits of traditional tools.
-
Q&A with Affiliate Austan Goolsbee
Austan Goolsbee recently shared his thoughts on innovation, competition, and commercial litigation.
-
Implications of the Tyson Ruling for Class Certification
Could the Supreme Court’s decision lead to either tighter or weaker standards for class certification?
-
Q&A with Affiliate David Dranove
One of Analysis Group’s new affiliates discusses his recent research and its application to antitrust litigation.
-
The Biosimilar Revolution Is Just Beginning in the US
The widespread introduction of medicines that are “grown” biologically may be one of the most significant events to hit the drug industries in decades.
-
Affiliate Spotlight: Oliver Hart
Analysis Group congratulates Professor Hart on the work that earned him the Nobel Prize in Economics.
-
Will Expanded EEO-1 Data Collection Yield New Insights into Discrimination?
Proposed changes to employer reporting requirements may have implications for wage discrimination class actions.
-
Affiliate Roundtable: Privacy and Data Security
Three leading experts weigh in on some of the most pressing issues surrounding the collection, storage, use, and disclosure of consumer data.
-
Data Corner: Resolution of Federal Privacy & Data Security Cases: 1999–2016
There are many potential outcomes when these cases reach the class certification stage.
-
Evaluating Potential Development of a Broader Market for CO2 Allowance Trading
Analysis Group’s most recent report on carbon trading markets sheds light on the potential for expanding these types of efforts to reduce carbon dioxide emissions.
Case Outcomes
-
Recent Litigation
Below is a representative sampling of the complex matters in which Analysis Group has recently worked with top law firms, Fortune 500 companies, health care organizations, and government agencies worldwide.
Uruguay Prevails in Cigarette Packaging Arbitration Dispute with Philip Morris International
Daiichi Sankyo Awarded over $500 Million in Arbitration
ITC Invalidates Trademark in Victory for Analysis Group Client New Balance
Class Certification Denied in Favor of Analysis Group Client CBSI
Bausch + Lomb, Senju Prevail in PTAB RulingHighlights from Our Pro Bono Work
Our pro bono efforts encompass diverse matters in social innovation, legal assistance, health care, and other areas. We work with nonprofit, governmental, and private organizations, both domestically and in other countries, that are targeting traditionally underserved locales and populations. Our pro bono efforts are driven by our people, at all levels of the firm, who take the initiative to pursue socially beneficial work for organizations that may not be able to commit the level of resources needed on their own. Our recent pro bono projects include the following:
Assisting Harvard Medical School faculty by applying machine learning techniques to the tuberculosis genome to predict drug resistance
Continuing a long-term partnership with GHESKIO on a range of issues associated with HIV and TB treatment in urban slums in Haiti
Helping the Massachusetts Housing and Shelter Alliance determine the cost savings resulting from moving homeless individuals with high utilization of emergency services into permanent housing
Teaming with Partners in Health to conduct a study of a hospital's construction and operation in Rwanda
Working with Massachusetts General Hospital and Harvard University to quantify the parental out-of-pocket medical costs associated with raising a child with Down syndrome
Also Featured on analysisgroup.com
-
Decision Making in a World of Comparative Effectiveness Research
Decision Making in a World of Comparative Effectiveness Research, a new book edited by Howard G. Birnbaum and Paul E. Greenberg, is a guide for real-world CER analysis and interpretation for use by decision makers. The chapters are authored by senior industry executives, key opinion leaders, accomplished researchers, and leading life sciences attorneys. The book is intended for decision makers who wish to make the best use of CER in today’s landscape of big data and enhanced methodology.
Martha Samuelson Recognized as One of Global Competition Review’s Women in Antitrust
Martha Samuelson has been recognized as one of 10 economists on Global Competition Review’s (GCR’s) distinguished list of Women in Antitrust 2016. The list is part of a broader GCR profile of women considered among the top private practitioners, enforcers, in-house counsel, economists, and academics in antitrust, and recognizes those who have been at the forefront of competition law and made groundbreaking contributions to the competition landscape.